458 related articles for article (PubMed ID: 17950557)
1. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes.
Tan CK; Liaw SJ; Yu CJ; Teng LJ; Hsueh PR
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):205-10. PubMed ID: 17950557
[TBL] [Abstract][Full Text] [Related]
2. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
Garazi M; Singer C; Tai J; Ginocchio CC
J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation.
Liaw SJ; Lee YL; Hsueh PR
Int J Antimicrob Agents; 2010 Feb; 35(2):126-30. PubMed ID: 19926255
[TBL] [Abstract][Full Text] [Related]
7. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital.
Gülmez D; Hasçelik G
Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102
[TBL] [Abstract][Full Text] [Related]
8. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
9. The emergence of Stenotrophomonas maltophilia as a significant nosocomial pathogen at the University Hospital of the West Indies.
Nicholson AM; Castle D; Akpaka P; Tennant I; Nelson M
West Indian Med J; 2004 Jan; 53(1):17-22. PubMed ID: 15114888
[TBL] [Abstract][Full Text] [Related]
10. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
11. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
[TBL] [Abstract][Full Text] [Related]
12. The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004.
Jumaa PA; Sonnevend A; Pàl T; El Hag M; Amith R; Trad O
Ann Clin Microbiol Antimicrob; 2006 Dec; 5():32. PubMed ID: 17194302
[TBL] [Abstract][Full Text] [Related]
13. Pseudooutbreak of Stenotrophomonas maltophilia bacteremia in a general ward.
Park YS; Kim SY; Park SY; Kang JH; Lee HS; Seo YH; Cho YK
Am J Infect Control; 2008 Feb; 36(1):29-32. PubMed ID: 18241733
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
Calza L; Manfredi R; Chiodo F
Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
[TBL] [Abstract][Full Text] [Related]
15. Attributable mortality of Stenotrophomonas maltophilia bacteremia.
Senol E; DesJardin J; Stark PC; Barefoot L; Snydman DR
Clin Infect Dis; 2002 Jun; 34(12):1653-6. PubMed ID: 12032905
[TBL] [Abstract][Full Text] [Related]
16. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
17. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital.
Metan G; Hayran M; Hascelik G; Uzun O
Scand J Infect Dis; 2006; 38(6-7):527-31. PubMed ID: 16798705
[TBL] [Abstract][Full Text] [Related]
18. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital.
Sattler CA; Mason EO; Kaplan SL
Clin Infect Dis; 2000 Dec; 31(6):1321-30. PubMed ID: 11095997
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia as a nosocomial pathogen.
Köseoğlu O; Sener B; Gülmez D; Altun B; Gür D
New Microbiol; 2004 Jul; 27(3):273-9. PubMed ID: 15460530
[TBL] [Abstract][Full Text] [Related]
20. An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital.
Caylan R; Kaklikkaya N; Aydin K; Aydin F; Yilmaz G; Ozgumus B; Koksal I
Jpn J Infect Dis; 2004 Apr; 57(2):37-40. PubMed ID: 15118205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
